December 27, 2016
1 min read
Save

FDA approves AcrySof IQ ReSTOR +3.0 D multifocal toric IOL

The FDA has approved Alcon’s AcrySof IQ ReSTOR +3.0 D multifocal toric IOL, according to a company press release.

The lens is designed for the treatment of both presbyopia and corneal astigmatism in adult patients at the time of cataract surgery, the release said. It is already available in the European Union, Australia, Canada, and multiple countries throughout Central and South America and Asia.

Commercial rollout will begin in the U.S. in the first quarter of 2017, according to the release.